Merck KGaA, Pfizer sales and marketing update

Merck's Merck Serono S.A. division and Pfizer launched a $0 co-pay program for Rebif interferon beta-1a to treat multiple sclerosis as part of MS LifeLines Access Made Simple program. Patients in t...